Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-20-040643
Filing Date
2020-02-18
Accepted
2020-02-18 17:15:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-1 d885226df1.htm F-1 618122
2 EX-5.1 d885226dex51.htm EX-5.1 54635
3 EX-23.1 d885226dex231.htm EX-23.1 1585
4 EX-23.2 d885226dex232.htm EX-23.2 1717
5 GRAPHIC g885226g31d61.jpg GRAPHIC 114663
6 GRAPHIC g885226g32e42.jpg GRAPHIC 46442
7 GRAPHIC g885226g45t06.jpg GRAPHIC 119588
  Complete submission text file 0001193125-20-040643.txt   1064133
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-236497 | Film No.: 20626380
SIC: 2834 Pharmaceutical Preparations